Skip to main content
Vistin Pharma logo

Vistin Pharma — Investor Relations & Filings

Ticker · VISTN ISIN · NO0010734122 LEI · 5967007LIEEXZXFQY092 OL Manufacturing
Open in API
Filings indexed 519 across all filing types
Latest filing 2026-04-24 Earnings Release
Country NO Norway
Listing OL VISTN

About Vistin Pharma

https://www.vistin.com/

Vistin Pharma is a pharmaceutical company specializing in the production of Metformin Hydrochloride, an Active Pharmaceutical Ingredient (API). The company operates as a pure-play, global supplier, providing high-quality Metformin to pharmaceutical companies worldwide. In addition to the standard API, Vistin Pharma offers specialized grades such as Direct Compressible (DC) Metformin. With over 50 years of experience, the company emphasizes sustainable manufacturing from its dedicated European production facility.

Recent filings

Filing Released Lang Actions
Vistin Pharma ASA: First quarter 2026 financial results
Earnings Release Classification · 95% confidence The document provides a concise summary of first‐quarter financial results (revenue, EBITDA, net profit, net cash), CEO commentary, dividend proposal, and details on the earnings conference call. It does not present the full interim report itself but serves as the initial public announcement of the quarter’s key financial metrics. This matches the definition of an Earnings Release (ER). Q1 2026
2026-04-24 English
Vistin Pharma ASA: Invitation to Q1 2026 conference call
Report Publication Announcement Classification · 75% confidence The document is a brief announcement inviting investors to a conference call and stating the timing for the Q1 2026 results release. It does not contain the actual results or transcript but merely announces the upcoming publication of the report and call details. Under the “menu vs meal” rule, this is an announcement regarding the timing/release of a report (and related investor event), which matches the Report Publication Announcement category (RPA).
2026-04-17 English
Vistin Pharma ASA (VISTN): Invitation to Q4 2025 conference call
Report Publication Announcement Classification · 100% confidence The document is an invitation to a conference call regarding the upcoming release of Q4 2025 financial results. It does not contain the actual financial results or the transcript of the call itself. According to the 'Menu vs Meal' rule, an announcement regarding the timing and access details for a future report or event is classified as a Report Publication Announcement (RPA).
2026-02-05 English
Vistin Pharma ASA: Third quarter and YTD 2025 financial results - Attachment: Vistin Pharma_Q3_25_presentation.pdf
Investor Presentation Classification · 100% confidence The document is a slide deck presentation titled 'Presentation 2025' dated 31 October 2025. It contains financial highlights, market overviews, and detailed financial tables (income statement, balance sheet) for Q3 2025. It is clearly an investor-facing presentation detailing the company's performance and strategy, which fits the definition of an Investor Presentation.
2025-10-31 English
Vistin Pharma ASA: Third quarter and YTD 2025 financial results - Attachment: Vistin Pharma ASA Q3 report 2025.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the third quarter (Q3) and year-to-date (YTD) 2025. It contains detailed financial statements, including revenue, EBITDA, cash flow, balance sheet data, and management's analysis of business trends, market outlook, and operational status. It is not an earnings release (which would be a short summary) nor a report publication announcement (as it contains the full report content). Therefore, it is classified as an Interim/Quarterly Report. Q3 2025
2025-10-31 English
Vistin Pharma ASA: Third quarter and YTD 2025 financial results
Earnings Release Classification · 100% confidence The document is a short announcement (approx. 2,000 characters) that summarizes key financial highlights (Revenue, EBITDA, Net Profit) for the third quarter of 2025. It explicitly states 'Please find the Q3 report and presentation enclosed', which confirms that this document is an announcement of the report rather than the full report itself. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA). Q3 2025
2025-10-31 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.